title: [Cancer, thromboembolia and antithrombotic                                         therapy: is there an anticoagulant of choice?].
authors.affiliation: Institut für Hämostaseologie, Hämotherapieund Transfusionsmedizin, Düsseldorf.
authors.forename: R E
authors.initials: RE
authors.lastname: Scharf
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D008134:Long-Term Care; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy* / Q000401:mortality; D010342:Patient Acceptance of Health Care; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention; D016019:Survival Analysis; D013917:Thrombin / Q000037:antagonists & inhibitors; D054556:Venous Thromboembolism / Q000188:drug therapy* / Q000401:mortality; D014812:Vitamin K / Q000037:antagonists & inhibitors
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014812:Vitamin K; D006493:Heparin; D013917:Thrombin